Literature DB >> 26838482

A retrospective review of safety using a nursing driven protocol for autonomic dysreflexia in patients with spinal cord injuries.

Ryan Solinsky1, Jelena N Svircev1,2, Jennifer J James3, Stephen P Burns1,2, Aaron E Bunnell1,4.   

Abstract

OBJECTIVE/
BACKGROUND: Autonomic dysreflexia is a potentially life-threatening condition which afflicts a significant proportion of individuals with spinal cord injuries (SCI). To date, the safety and efficacy of several commonly used interventions for this condition have not been studied.
DESIGN: A retrospective chart review of the safety of a previously implemented nursing driven inpatient autonomic dysreflexia protocol.
METHODS: Seventy-eight male patients with SCI who experienced autonomic dysreflexia while inpatient at our Veterans Affairs SCI unit over a 3-1/2-year period were included. The safety of a nursing driven protocol utilizing conservative measures, nitroglycerin paste, and oral hydralazine was evaluated. OUTCOME MEASURES: Occurrence of adverse events and relative hypotensive events during all episodes treated with the protocol, and efficacy of attaining target blood pressure for all episodes with protocol adherence and for initial episode experienced by each patient.
RESULTS: Four hundred forty-five episodes of autonomic dysreflexia were recorded in the study period, with 92% adherence to the protocol. When the protocol was followed, target blood pressure was achieved for 97.6% of all episodes. Twenty-three total adverse events occurred (5.2% of all episodes). All adverse events were due to hypotension and only 0.9% required interventions beyond clinical monitoring. Of each patient's initial autonomic dysreflexia episode, 97.3% resolved using the protocol without need for further escalation of care.
CONCLUSION: This inpatient nursing driven-protocol for treating autonomic dysreflexia utilizing conservative measures, nitroglycerin paste and oral hydralazine achieved target blood pressure with a high success rate and a low incidence of adverse events.

Entities:  

Keywords:  Autonomic dysreflexia; Hydralazine; Nitroglycerin; Spinal cord injuries

Mesh:

Substances:

Year:  2015        PMID: 26838482      PMCID: PMC5137561          DOI: 10.1080/10790268.2015.1118186

Source DB:  PubMed          Journal:  J Spinal Cord Med        ISSN: 1079-0268            Impact factor:   1.985


  20 in total

Review 1.  Autonomic dysreflexia.

Authors:  A K Karlsson
Journal:  Spinal Cord       Date:  1999-06       Impact factor: 2.772

Review 2.  A systematic review of the management of autonomic dysreflexia after spinal cord injury.

Authors:  Andrei Krassioukov; Darren E Warburton; Robert Teasell; Janice J Eng
Journal:  Arch Phys Med Rehabil       Date:  2009-04       Impact factor: 3.966

3.  Autonomic dysreflexia. A survey of current treatment.

Authors:  R L Braddom; J F Rocco
Journal:  Am J Phys Med Rehabil       Date:  1991-10       Impact factor: 2.159

4.  Can epidural fentanyl control autonomic hyperreflexia in a quadriplegic parturient?

Authors:  E I Abouleish; E S Hanley; S M Palmer
Journal:  Anesth Analg       Date:  1989-04       Impact factor: 5.108

5.  Neutralizing intraspinal nerve growth factor blocks autonomic dysreflexia caused by spinal cord injury.

Authors:  N R Krenz; S O Meakin; A V Krassioukov; L C Weaver
Journal:  J Neurosci       Date:  1999-09-01       Impact factor: 6.167

6.  A study of the alpha-1 adrenoceptor blocker prazosin in the prophylactic management of autonomic dysreflexia in high spinal cord injury patients.

Authors:  H Krum; W J Louis; D J Brown; L G Howes
Journal:  Clin Auton Res       Date:  1992-04       Impact factor: 4.435

7.  Severe hypertension in patients with high spinal cord lesions undergoing electro-ejaculation--management with prostaglandin E2.

Authors:  H L Frankel; C J Mathias
Journal:  Paraplegia       Date:  1980-10

8.  Pathophysiology of autonomic dysreflexia: long-term treatment with terazosin in adult and paediatric spinal cord injury patients manifesting recurrent dysreflexic episodes.

Authors:  S Vaidyanathan; B M Soni; P Sett; J W Watt; T Oo; J Bingley
Journal:  Spinal Cord       Date:  1998-11       Impact factor: 2.772

9.  Effect of nifedipine on cystometry-induced elevation of blood pressure in patients with a reflex urinary bladder after a high level spinal cord injury.

Authors:  M Thyberg; P Ertzgaard; M Gylling; G Granerus
Journal:  Paraplegia       Date:  1994-05

10.  Orthostatic hypotension-induced autonomic dysreflexia.

Authors:  R K Khurana
Journal:  Neurology       Date:  1987-07       Impact factor: 9.910

View more
  7 in total

1.  Recognizing the role of research in improving care for spinal cord injury: the Bors Award.

Authors:  Florian P Thomas; Carolann Murphy; Stephen Cavanaugh
Journal:  J Spinal Cord Med       Date:  2017-03-22       Impact factor: 1.985

2.  Celebrating advances in spinal cord injury care and research.

Authors:  Florian P Thomas; Carolann Murphy
Journal:  J Spinal Cord Med       Date:  2018-09       Impact factor: 1.985

3.  Anxiety masquerading as autonomic dysreflexia.

Authors:  Ryan Solinsky; Todd A Linsenmeyer
Journal:  J Spinal Cord Med       Date:  2018-09-10       Impact factor: 1.985

4.  Exploring detailed characteristics of autonomic dysreflexia.

Authors:  Ryan Solinsky; Steven C Kirshblum; Stephen P Burns
Journal:  J Spinal Cord Med       Date:  2017-08-07       Impact factor: 1.985

5.  Pharmacodynamics and effectiveness of topical nitroglycerin at lowering blood pressure during autonomic dysreflexia.

Authors:  R Solinsky; A E Bunnell; T A Linsenmeyer; J N Svircev; A Engle; S P Burns
Journal:  Spinal Cord       Date:  2017-06-06       Impact factor: 2.772

Review 6.  Toward rebalancing blood pressure instability after spinal cord injury with spinal cord electrical stimulation: A mini review and critique of the evolving literature.

Authors:  Madeleine Burns; Ryan Solinsky
Journal:  Auton Neurosci       Date:  2021-11-11       Impact factor: 2.355

7.  High-intensity, whole-body exercise improves blood pressure control in individuals with spinal cord injury: A prospective randomized controlled trial.

Authors:  Ryan Solinsky; Adina Draghici; Jason W Hamner; Rich Goldstein; J Andrew Taylor
Journal:  PLoS One       Date:  2021-03-04       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.